-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Pasithea Therapeutics Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2024.
- Pasithea Therapeutics Corp. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$3.18M, a 37.1% increase year-over-year.
- Pasithea Therapeutics Corp. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$13.9M, a 12.9% increase year-over-year.
- Pasithea Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2024 was -$13.9M, a 12.9% increase from 2023.
- Pasithea Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$16M, a 14.5% decline from 2022.
- Pasithea Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.9M, a 541% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)